Daniel E. Troy

Daniel E. Troy

Senior Vice President and General Counsel, GlaxoSmithKline

Topics: Administrative Law & Regulation • Federalism & Separation of Powers • Litigation

Dan Troy joined GSK as Senior Vice President & General Counsel in September 2008. Reporting to Andrew Witty, he is based in Franklin Plaza, Philadelphia PA, and is a member of the Corporate Executive Team.
Previously a Partner at the Washington law firm Sidley Austin LLP, where he represented mainly pharmaceutical companies and trade associations on matters related to the US Food and Drug Administration (FDA) and government regulations, Dan was formerly Chief Counsel for the FDA, where he served as a primary liaison to the White House and the US Department of Health and Human Services (HHS).

While leading an office of attorneys who reviewed and approved all major regulations and guidances, Dan oversaw the legislative implications of many of the most important issues facing the pharmaceutical industry today, including the reform of the Hatch-Waxman Act and subsequent legislative ratification. His office also approved and managed all agency litigation, and Dan established procedures for the FDA legal team to follow in preparing and then litigating high-profile cases.

Dan is a graduate from Cornell University’s School of Industrial and Labor Relations, and earned his law degree from Columbia University School of Law, where he was a member of the Law Review and a Kent Scholar. After graduation from law school, he was a law clerk for the US Circuit Court of Appeals for the District of Columbia Circuit.